Generic Name: betamethasone topical
Applies to betamethasone topical: topical application cream, topical application foam, topical application gel/jelly, topical application lotion, topical application ointment
Other dosage forms:
As well as its needed effects, betamethasone topical (the active ingredient contained in Sernivo) may cause unwanted side effects that require medical attention. 
If any of the following side effects occur while taking betamethasone topical, check with your doctor immediately:
Some betamethasone topical side effects may not need any medical attention. As your body gets used to the medicine these side effects may disappear. Your health care professional may be able to help you prevent or reduce these side effects, but do check with them if any of the following side effects continue, or if you are concerned about them:


Applies to betamethasone topical: topical cream, topical foam, topical gel, topical lotion, topical ointment, topical spray
The most commonly reported side effects were pruritus, burning, itching, irritation.
Rare (less than 0.1%): Hypersensitivity
Frequency not reported: Cushing's syndrome[Ref]
Common (1% to 10%): PruritusUncommon (0.1% to 1%): Folliculitis, skin infections (including bacterial, fungal and viral skin infections)Frequency not reported: Dryness, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infections, skin atrophy, striae, miliaria[Ref]
Uncommon (0.1% to 1%): Application site painFrequency not reported: Burning, itching, irritation[Ref]
Rare (less than 0.1%): Eye disorder[Ref]
Frequency not reported: Hyperglycemia
Frequency not reported: Glucosuria
Rare (less than 0.1%): Rebound effect
1. Ruiz-Maldonado R, Zapata G, Lourdes T, Robles C "Cushing's syndrome after topical application of corticosteroids." Am J Dis Child 136 (1982): 274-5
2. "Product Information. Diprolene (betamethasone topical)." Schering Laboratories, Kenilworth, NJ. 
3. Flynn MD, Beasley P, Tooke JE "Adrenal suppression with intranasal betamethasone drops." J Laryngol Otol 106 (1992): 827-8
4. Stoppoloni G, Prisco F, Santinelli R, Sicuranza G, Giordano C "Potential hazards of topical steroid therapy." Am J Dis Child 137 (1983): 1130-1
5. Stevens DJ "Cushing's syndrome due to the abuse of betamethasone nasal drops." J Laryngol Otol 102 (1988): 219-21
6. Walsh P, Aeling JL, Huff L, Weston WL "Hypothalamus-pituitary-adrenal axis suppression by superpotent topical steroids." J Am Acad Dermatol 29 (1993): 501-3
7. Salde L, Lassus A "Systemic side-effects of three topical steroids in diseased skin." Curr Med Res Opin 8 (1983): 475-80
8. Reymann F, Kehlet H "Hypothalamic-pituitary-adrenocortical function. Association with topical application of betamethasone dipropionate." Arch Dermatol 115 (1979): 362-3
9. Cunliffe WJ, Burton JL, Holti G, Wright V "Hazards of steroid therapy in hepatic failure." Br J Dermatol 93 (1975): 183-5
10. Macdonald A "Topical corticosteroid preparations. Hazards and side-effects." Br J Clin Pract 25 (1971): 421-5
11. Smith EB, Breneman DL, Griffith RF, Hebert AA, Hickman JG, Maloney JM, Millikan LE, Sulica VI, Dromgoole SH, Sefton J, et al "Double-blind comparison of naftifine cream and clotrimazole/betamethasone dipropionate cream in the treatment of tinea pedis." J Am Acad Dermatol 26 (1992): 125-7
12. Grice K "Tinea of the hand and forearm. Betamethasone valerate atrophy." Proc R Soc Med 59 (1966): 254-5
13. Hellgren L "Induction of generalized pustular psoriasis by topical use of betamethasone-dipropionate ointment in psoriasis." Ann Clin Res 8 (1976): 317-9
14. Barkey WF "Striae and persistent tinea corporis related to prolonged use of betamethasone dipropionate 0.05% cream/clotrimazole 1% cream (Lotrisone cream)." J Am Acad Dermatol 17 (1987): 518-9
15. Ellis CN, Katz HI, Rex IH Jr, Shavin JS, Van Scott EJ, VanderPloeg D "A controlled clinical trial of a new formulation of betamethasone dipropionate cream in once-daily treatment of psoriasis." Clin Ther 11 (1989): 768-74
16. Sneddon I "Perioral dermatitis." Br J Dermatol 87 (1972): 430-4
17. Butcher JM, Austin M, McGalliard J, Bourke RD "Bilateral cataracts and glaucoma induced by long term use of steroid eye drops." BMJ 309 (1994): 43
18. Eisenlohr JE "Glaucoma following the prolonged use of topical steroid medication to the eyelids." J Am Acad Dermatol 8 (1983): 878-81
19. Kitazawa Y "Increased intraocular pressure induced by corticosteroids." Am J Ophthalmol 82 (1976): 492-5
It is possible that some side effects of Sernivo may not have been reported. These can be reported to the FDA here. Always consult a healthcare professional for medical advice.
topical application cream, topical application lotion, topical application ointment, topical application spray

Burning, itching, or stinging at the application site


Hair loss
thinning of the hair


Blistering, burning, crusting, dryness, or flaking of the skin
irritation
itching, scaling, severe redness, soreness, or swelling of the skin
redness and scaling around the mouth
thinning of the skin with easy bruising, especially when used on where the skin folds together (e.g. between the fingers)


Acne or pimples
burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings


Burning and itching of the skin with pinhead-sized red blisters
burning, itching, and pain in hairy areas, or pus at the root of the hair
increased hair growth on the forehead, back, arms, and legs
lightening of normal skin color
lightening of treated areas of dark skin
reddish purple lines on the arms, face, legs, trunk, or groin
softening of the skin

